Belimumab Vials and Dihydrocodeine, Aspirin, and Caffeine
Determining the interaction of Belimumab Vials and Dihydrocodeine, Aspirin, and Caffeine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: belimumab
Brand name: Benlysta, Benlysta Autoinjector
Synonyms: Belimumab
Generic Name: aspirin / caffeine / dihydrocodeine
Brand name: Synalgos-DC
Synonyms: Aspirin, caffeine, and dihydrocodeine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Belimumab Vials-Dihydroergotamine
- Belimumab Vials-Dihydroergotamine injection
- Belimumab Vials-Dihydroergotamine Mesylate
- Belimumab Vials-Dihydroergotamine nasal
- Belimumab Vials-Dihydroergotamine Nasal Spray
- Belimumab Vials-Dilacor XR
- Dihydrocodeine, Aspirin, and Caffeine-Belinostat
- Dihydrocodeine, Aspirin, and Caffeine-Belinostat Intravenous
- Dihydrocodeine, Aspirin, and Caffeine-Belladonna
- Dihydrocodeine, Aspirin, and Caffeine-Belladonna alkaloids and phenobarbital
- Dihydrocodeine, Aspirin, and Caffeine-Belladonna and Opium
- Dihydrocodeine, Aspirin, and Caffeine-Belladonna and opium rectal